# Michael Walsh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-walsh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,950 |
| Field | Vasculitis and related conditions |
| h-index | 64 |
| i10-index | 160 |
| Last Known Institution | St. Joseph’s Healthcare Hamilton |
| OpenAlex ID | https://openalex.org/A5013696488 |
| ORCID iD | https://orcid.org/0000-0001-8292-2014 |
| Works | 262 |

## Researcher papers

Showing 12 of 14.

- [Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis/)
- [Discrimination and Calibration of Clinical Prediction Models](https://scholariq.org/papers/discrimination-and-calibration-of-clinical-prediction-models/)
- [Myocardial Injury after Noncardiac Surgery](https://scholariq.org/papers/myocardial-injury-after-noncardiac-surgery/)
- [Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis](https://scholariq.org/papers/plasma-exchange-and-glucocorticoids-in-severe-anca-associated-vasculitis/)
- [Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses](https://scholariq.org/papers/development-of-the-instrument-to-assess-the-credibility-of-effect-modification/)
- [Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life](https://scholariq.org/papers/effect-of-frequent-nocturnal-hemodialysis-vs-conventional-hemodialysis-on-left/)
- [Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis](https://scholariq.org/papers/mycophenolate-mofetil-vs-azathioprine-for-remission-maintenance-in/)
- [Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/potassium-homeostasis-and-management-of-dyskalemia-in-kidney-diseases/)
- [Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up](https://scholariq.org/papers/pulse-versus-daily-oral-cyclophosphamide-for-induction-of-remission-in-anca/)
- [Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis-2-year/)
- [Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-remission-induction-in-anca/)
- [Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop](https://scholariq.org/papers/establishing-core-outcome-domains-in-hemodialysis-report-of-the-standardized/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [St. Joseph’s Healthcare Hamilton](https://scholariq.org/institutions/st-joseph-s-healthcare-hamilton/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.